Breaking the First Plateau For patients who have made behavioral changes but hit a plateau where weight won't move, Phentermine provides the pharmaceutical push that breaks through metabolic resistance
Mild to moderate transient gastrointestinal side effects were the most frequently reported adverse events associated with tirzepatide treatment and were similar in frequency and intensity compared to semaglutide (nausea 17%22% vs
NAD+ is the better first move when the presenting complaint is systemic: fatigue, brain fog, metabolic slowdown, or recovery from chronic stress
They also influence parts of the brain involved in appetite, reward and inflammation
PlexusDx's Precision Peptide Genetic Test ($298) analyzes variants in GIPR, FTO, and MC4R, and 10 additional pathways controlling appetite, glucose metabolism, and satiety signaling
Key highlights Broad catalog